No abstract available
MeSH terms
-
Angiogenesis Inhibitors / administration & dosage*
-
Angiogenesis Inhibitors / adverse effects*
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bevacizumab
-
Capecitabine
-
Colonic Diseases / chemically induced*
-
Colonic Diseases / therapy*
-
Colorectal Neoplasms / therapy*
-
Deoxycytidine / administration & dosage
-
Deoxycytidine / adverse effects
-
Deoxycytidine / analogs & derivatives
-
Drug-Related Side Effects and Adverse Reactions
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Fluorouracil / analogs & derivatives
-
Humans
-
Intestinal Obstruction / therapy*
-
Intestinal Perforation / chemically induced*
-
Organoplatinum Compounds / administration & dosage
-
Organoplatinum Compounds / adverse effects
-
Oxaliplatin
-
Rupture, Spontaneous
-
Stents*
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Organoplatinum Compounds
-
Oxaliplatin
-
Deoxycytidine
-
Bevacizumab
-
Capecitabine
-
Fluorouracil